Quick answer
As of September 26, 2026, e-prescribing is the electronic transmission of a prescription from the prescriber's software directly to the pharmacy named on the prescription, with no paper script or fax in between. The clinician enters the medication, quantity, and directions, selects the pharmacy, and signs electronically; a secure network delivers the prescription to that pharmacy's queue, and a pharmacist reviews and fills it. For controlled substances, federal DEA rules in 21 CFR Part 1311 add identity proofing and two-factor authentication for the prescriber. For a telehealth patient, e-prescribing is the last step: the online visit ends with the prescription already in the system of a retail, mail-order, or state-licensed compounding pharmacy.
E-prescribing is the system that moves a prescription electronically from your clinician's software to your pharmacy's system, with no paper involved. The clinician writes and signs the prescription digitally; a secure network delivers it to the pharmacy named on the prescription; the pharmacy fills it. In the United States, this is how the large majority of prescriptions travel today.
If you have ever had a telehealth visit and wondered how the medication actually gets from a decision on a screen to a bag at the pharmacy counter or a box at your door, this is the machinery in between.
How does e-prescribing work?
The path from decision to pharmacy has five stops:
- The clinician writes the prescription in their software. Medication, strength, quantity, directions, refills: the same elements you later see on the label, entered into a system that checks them against your recorded allergies and current medications as they type.
- They select the pharmacy. Depending on the service, that is a retail pharmacy near you, a mail-order pharmacy, or, for compounded medications, the compounding pharmacy that will prepare your specific formulation.
- They sign electronically. The prescriber's identity is verified on every transmission. For controlled substances, federal EPCS rules add identity-proofing and two-factor authentication on top.
- The network routes it. Most US e-prescriptions travel through Surescripts, a network connecting prescriber systems and pharmacy systems nationwide. Delivery to the pharmacy's queue typically takes seconds to minutes.
- The pharmacy takes over. A pharmacist reviews the prescription, runs interaction checks of their own, prepares the medication, and notifies you when it is ready for pickup or has shipped.
The practical difference from paper: nothing to lose, nothing illegible, and a complete audit trail from signature to shelf.
Where telehealth fits
For an online visit, e-prescribing is the last mile. The evaluation happens remotely, and if the clinician decides treatment is appropriate, the prescription enters the same national machinery every in-person clinic uses: same network, same pharmacy checks, same rules. Our guide to your first telehealth visit covers the evaluation side; this article is what happens after the clinician clicks sign.
Two details worth knowing for telehealth specifically:
- The prescriber must be licensed in your state, and the prescription shows their name; you can verify any prescriber's license in minutes.
- The pharmacy is named. You should always know which pharmacy received your prescription, and it appears on your medication label when the medication arrives.
What patients should check
E-prescribing removes most paper-era failure modes, but a short checklist on your end still helps:
- Confirm the pharmacy before the visit ends: name and location (or, for mail-order and compounding pharmacies, the name and the state it ships from).
- Ask when to expect it. Retail fills are often same-day; mail-order and compounded preparations take longer because preparation and shipping are involved.
- Check the label on arrival against what the clinician told you: medication, strength, directions, prescriber name.
- If nothing arrives, call the pharmacy first (the prescription may be in their queue awaiting stock or clarification), then the prescriber's office.
The bottom line
E-prescribing is the quiet infrastructure that makes modern prescribing work: a signed, verified, traceable transmission from the clinician's software to the pharmacy named on the prescription, used for the large majority of US prescriptions. For a telehealth patient, it means an online visit ends the same way an office visit does, with your prescription already waiting in the pharmacy's system. How this whole process is designed to work at Majesta, from assessment to a state-licensed 503A pharmacy, is described at how Majesta works.
What the primary sources say
- Centers for Medicare & Medicaid Services, E-Prescribing (accessed September 26, 2026): "E-prescribing enables a prescriber to electronically send an accurate, error-free and understandable prescription directly to a pharmacy from the point-of-care and is an important element in improving the quality of patient care."
- Legal Information Institute (Cornell), 21 CFR 1311.100 General (accessed September 26, 2026): "This subpart addresses the requirements that must be met to issue and process Schedule II, III, IV, and V controlled substance prescriptions electronically."
- Legal Information Institute (Cornell), 21 CFR 1311.115 Additional requirements for two-factor authentication (accessed September 26, 2026): "To sign a controlled substance prescription, the electronic prescription application must require the practitioner to authenticate to the application using an authentication protocol that uses two of the following three factors"
- Legal Information Institute (Cornell), 21 CFR 1311.105 Requirements for obtaining an authentication credential, individual practitioners (accessed September 26, 2026): "The practitioner must submit identity proofing information to the credential service provider or certification authority as specified by the credential service provider or certification authority."
- Legal Information Institute (Cornell), 21 CFR 1306.25 Transfer between pharmacies of prescription information for Schedules III, IV, and V controlled substances for refill purposes (accessed September 26, 2026): "The transfer of original prescription information for a controlled substance listed in Schedule III, IV, or V for the purpose of refill dispensing is permissible between pharmacies on a one-time basis only."
Sources: Surescripts National Progress Report data on US e-prescribing adoption; DEA EPCS regulations (21 CFR Part 1311); ONC (HealthIT.gov) patient resources on electronic prescribing; state board of pharmacy transfer rules.
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Compounded medications are not FDA-approved as final products. Medication is prescribed only if a licensed physician determines it is appropriate.
Frequently Asked Questions
What is e-prescribing?
E-prescribing (electronic prescribing) is the transmission of a prescription directly from the prescriber's clinical software to a pharmacy's system over a secure network, replacing paper scripts and faxes. In the United States the large majority of prescriptions travel this way, most of them through the Surescripts network, which connects prescribers, pharmacies, and pharmacy benefit systems.
How does e-prescribing work, step by step?
After the clinician decides to prescribe, they select the medication, strength, quantity, and directions in their e-prescribing software, choose the patient's pharmacy, and sign the prescription electronically. The network routes it to that pharmacy's queue within seconds to minutes. The pharmacy then verifies the prescription, checks for interactions, prepares the medication, and notifies the patient when it is ready or shipped.
Can an e-prescription go to any pharmacy?
It goes to the specific pharmacy the prescriber selected, and you should be told which one. If you want it somewhere else afterward, you do not need a new prescription in most cases: pharmacies can transfer many prescriptions between each other, though rules are stricter for controlled substances. For compounded medications the prescription goes to the compounding pharmacy that will prepare that specific formulation.
Why did e-prescribing replace paper prescriptions?
Fewer errors and less friction at every step: no lost or illegible scripts, automatic checks against the patient's medication list, verified prescriber identity on every transmission, and an audit trail for every prescription. For controlled substances, federal rules (EPCS) add identity-proofing and two-factor authentication for the prescriber, which paper never had.
What should I do if the pharmacy says it never received my e-prescription?
Call the pharmacy first and ask them to check their electronic queue, because a prescription can sit there awaiting stock, a clarification, or a pharmacist review before it is filled. If the pharmacy has no record of it, contact the prescriber's office and confirm which pharmacy was selected at the visit; a prescription sent to the wrong location can be reissued or transferred. Keep the prescriber's name and the pharmacy name handy for both calls.
Does e-prescribing work for compounded medications?
Yes. The prescription is transmitted the same way, but it goes to the specific compounding pharmacy that will prepare your individual formulation rather than to a retail counter. That pharmacy must be state-licensed, and its name should appear on the medication label when your order arrives. Compounded preparations take longer than a retail fill because the pharmacy prepares and ships them after receiving the prescription. Compounded medications are not FDA-approved as final products.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.E-Prescribing · Centers for Medicare & Medicaid Services · accessed
- 2.21 CFR 1311.100 General (Subpart C, Electronic Prescriptions) · Legal Information Institute, Cornell Law School (eCFR text) · accessed
- 3.21 CFR 1311.115 Additional requirements for two-factor authentication · Legal Information Institute, Cornell Law School (eCFR text) · accessed
- 4.21 CFR 1311.105 Requirements for obtaining an authentication credential, individual practitioners · Legal Information Institute, Cornell Law School (eCFR text) · accessed
- 5.21 CFR 1306.25 Transfer between pharmacies of prescription information for Schedules III, IV, and V controlled substances for refill purposes · Legal Information Institute, Cornell Law School (eCFR text) · accessed
Is this available in your state?
Telehealth rules differ by state, and so does what a physician can prescribe remotely. Each state page covers the local telehealth requirements, whether a video visit is required, and the current status of our physician coverage there.
- California
- Texas
- Florida
- New York
- Pennsylvania
- Illinois
- Ohio
- Georgia
- North Carolina
- Michigan
- Arizona
- Washington
Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.
- Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
- Documented compliance review against FDA, FTC and LegitScript requirements before publication
- External sources, where an article cites them, are listed at the end of that article with links to the original documents
- Compounded medications are described as not FDA-approved as final products on every page that mentions them